Frankfurt - Delayed Quote EUR

Ovation Science Inc. (0VH.F)

0.0300 0.0000 (0.00%)
At close: April 26 at 8:16 AM GMT+2
Key Events
Loading Chart for 0VH.F
DELL
  • Previous Close 0.0300
  • Open 0.0290
  • Bid 0.0260 x --
  • Ask 0.0455 x --
  • Day's Range 0.0260 - 0.0290
  • 52 Week Range 0.0005 - 0.0335
  • Volume 184,800
  • Avg. Volume 0
  • Market Cap (intraday) 1.101M
  • Beta (5Y Monthly) 0.12
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Ovation Science Inc. engages in the production, sub-licensing and sales of cannabis or hemp products in Canada, the United States, and Mexico. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal cannabis products under the Ovation. It offers recreation transdermal cream under the BASKiN names; cannabidiol health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and hand sanitizers under the DermSafe name. Ovation Science Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.

ovationscience.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0VH.F

Performance Overview: 0VH.F

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

0VH.F
130.77%
S&P/TSX Composite index
4.82%

1-Year Return

0VH.F
1,100.00%
S&P/TSX Composite index
7.48%

3-Year Return

0VH.F
75.81%
S&P/TSX Composite index
15.01%

5-Year Return

0VH.F
--
S&P/TSX Composite index
32.22%

Compare To: 0VH.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0VH.F

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    1.10M

  • Enterprise Value

    1.22M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    15.62

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    14.80

  • Enterprise Value/EBITDA

    -1.59

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -277.17%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    82.69k

  • Net Income Avi to Common (ttm)

    -793.99k

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.4k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -16.86k

Company Insights: 0VH.F